← Back to Screener
Orthofix Medical Inc. Common Stock (DE) (OFIX)
Price$9.27
Value ScoreB
Growth ScoreC
Momentum ScoreD
Favorite Metrics
Price vs S&P 500 (26W)-51.06%
Price vs S&P 500 (4W)-27.14%
VGM Score47.86
Market Capitalization$374.71M
All Metrics
P/CF (Annual)11.24x
Book Value / Share (Quarterly)$10.78
P/TBV (Annual)1.59x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)21.30%
Cash Flow / Share (Quarterly)$-0.11
Price vs S&P 500 (YTD)-49.79%
Gross Margin (TTM)70.75%
Net Profit Margin (TTM)-7.27%
EPS (TTM)$-1.50
10-Day Avg Trading Volume0.60M
EPS Excl Extra (TTM)$-1.50
Revenue Growth (5Y)15.13%
EPS (Annual)$-2.33
ROI (Annual)-14.74%
Gross Margin (Annual)68.83%
Net Profit Margin (5Y Avg)-11.96%
Cash / Share (Quarterly)$2.98
Revenue Growth QoQ (YoY)1.58%
ROA (Last FY)-10.84%
Revenue Growth TTM (YoY)2.59%
EBITD / Share (TTM)$-0.85
ROE (5Y Avg)-17.61%
Operating Margin (TTM)-5.69%
Cash Flow / Share (Annual)$-0.03
P/B Ratio0.86x
P/B Ratio (Quarterly)1.06x
Net Income / Employee (Annual)$-57,400
EV / Revenue (TTM)0.59x
Net Interest Coverage (TTM)-4.19x
ROA (TTM)-7.04%
EV / EBITDA (TTM)257.27x
EPS Incl Extra (Annual)$-2.33
Current Ratio (Annual)2.45x
Quick Ratio (Quarterly)1.61x
3-Month Avg Trading Volume0.32M
52-Week Price Return-17.82%
Revenue / Employee (TTM)$514,300
Tangible BV / Share (Quarterly)$9.06
P/S Ratio (Annual)0.46x
Asset Turnover (Annual)0.97x
52-Week High$16.99
Operating Margin (5Y Avg)-8.76%
EPS Excl Extra (Annual)$-2.33
CapEx CAGR (5Y)7.34%
Tangible BV CAGR (5Y)4.94%
26-Week Price Return-35.13%
Quick Ratio (Annual)1.30x
13-Week Price Return-29.61%
Total Debt / Equity (Annual)0.39x
Current Ratio (Quarterly)2.87x
Enterprise Value$488.82M
Revenue / Share Growth (5Y)-0.19%
Asset Turnover (TTM)0.97x
Book Value / Share Growth (5Y)-9.29%
Revenue / Employee (Annual)$512,300
Inventory Turnover (Annual)1.42x
Pretax Margin (Annual)-11.04%
Cash / Share (Annual)$2.06
3-Month Return Std Dev46.26%
Gross Margin (5Y Avg)70.14%
Net Income / Employee (TTM)$-37,400
EBITDA Interim CAGR (5Y)-8.18%
ROE (Last FY)-20.49%
Net Interest Coverage (Annual)-2.19x
EPS Basic Excl Extra (Annual)$-2.33
P/FCF (TTM)15.71x
Receivables Turnover (TTM)6.12x
Total Debt / Equity (Quarterly)0.54x
EPS Incl Extra (TTM)$-1.50
Receivables Turnover (Annual)6.08x
ROI (TTM)-9.43%
P/S Ratio (TTM)0.45x
Pretax Margin (5Y Avg)-10.64%
Revenue / Share (Annual)$20.76
Tangible BV / Share (Annual)$9.47
Price vs S&P 500 (52W)-46.03%
Year-to-Date Return-38.85%
5-Day Price Return-13.77%
EPS Normalized (Annual)$-2.33
ROA (5Y Avg)-10.73%
Net Profit Margin (Annual)-11.21%
Month-to-Date Return-21.17%
Cash Flow / Share (TTM)$-2.76
EBITD / Share (Annual)$-1.34
Operating Margin (Annual)-9.90%
LT Debt / Equity (Annual)0.35x
P/CF (TTM)10.98x
ROI (5Y Avg)-14.15%
LT Debt / Equity (Quarterly)0.51x
EPS Basic Excl Extra (TTM)$-1.50
P/TBV (Quarterly)1.26x
P/B Ratio (Annual)1.33x
Inventory Turnover (TTM)1.37x
Pretax Margin (TTM)-7.21%
Book Value / Share (Annual)$11.30
Price vs S&P 500 (13W)-39.36%
Beta0.73x
P/FCF (Annual)7.49x
Revenue / Share (TTM)$20.40
ROE (TTM)-13.44%
52-Week Low$9.13
vGradeB
gGradeC
mGradeD
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.13est. -0.69
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.17
4.09
4.09
4.09
Industry Peers — Surgical & Medical Instruments(138)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
OFIXOrthofix Medical Inc. Common Stock (DE) | B | C | D | $9.27 |
| SYKStryker Corporation | C | C | D | $299.46 |
| MMM3M Company | C | F | C | $150.93 |
| BSXBoston Scientific Corp. | C | B | F | $47.98 |
| MDLNMedline Inc. Class A common stock | C | D | D | $35.75 |
| BDXBecton, Dickinson and Co. | B | C | C | $145.33 |
| DXCMDexCom, Inc. | C | B | C | $74.87 |
| RMDResMed Inc. | B | B | D | $186.44 |
| WSTWest Pharmaceutical Services, Inc. | D | C | B | $316.30 |
| SOLVSolventum Corporation | C | D | C | $75.84 |
| PENPenumbra, Inc. | F | C | C | $318.95 |
About
Orthofix Medical Inc. is a medical device company specializing in orthopedic and spine solutions. The Global Spine segment, which generates the majority of revenue, provides bone growth therapies, spinal implants, biologics, and enabling technologies for spinal procedures. The Global Limb Reconstruction segment offers solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies.